According to a new report from PricewaterhouseCoopers (PwC), the US market for personalized medicine will have a compound annual growth rate of 11% between 2009 and 2015. The market is currently estimated at $225–$232 billion and is expected to reach $344–$452 billion by 2015. PwC defines personalized medicine as: “products and services that leverage the science of genomics and proteomics (directly or indirectly) and capitalizes on the trends toward wellness and consumerism to enable tailored approaches to prevention and care.” The market is comprised of three segments. The $24 billion diagnostic and therapeutic segment consists of: target therapeutics ($13 billion), esoteric lab services ($6 billion), as well as esoteric test sales ($5 billion), which includes the $3 billion molecular diagnostics market. This segment is growing at an annual rate of 10%. The personalized medical care segment consists of the $2 billion market for electronic medical records, the $2 billion market for disease management services and the remote patient monitoring/telemedicine market, which is valued at up to $7 billion. Forecasted to grow 7% annually, the $196 billion nutrition and wellness segment is comprised of four submarkets: nutrition/organic care ($120 billion), complimentary and alternative medicines ($36 billion), health clubs and spas ($37 billion), and medical retail ($3 billion).

Source: PwC